• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-ASGR1

ASGR1 Monoclonal Antibody for IF-P

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, porc, rat, souris

Applications

IF-P

Conjugaison

PE Fluorescent Dye

CloneNo.

1G5F5

N° de cat : PE-66692

Synonymes

asialoglycoprotein receptor 1, HL-1, Asgpr1, ASGP-R 1, ASGPR 1



Applications testées

Résultats positifs en IF-Ptissu hépatique de rat,

Dilution recommandée

ApplicationDilution
Immunofluorescence (IF)-PIF-P : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

PE-66692 cible ASGR1 dans les applications de IF-P et montre une réactivité avec des échantillons Humain, porc, rat, souris

Réactivité Humain, porc, rat, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène ASGR1 Protéine recombinante Ag2310
Nom complet asialoglycoprotein receptor 1
Masse moléculaire calculée 291 aa, 33 kDa
Poids moléculaire observé 42-46 kDa
Numéro d’acquisition GenBankBC032130
Symbole du gène ASGR1
Identification du gène (NCBI) 432
Conjugaison PE Fluorescent Dye
Excitation/Emission maxima wavelengths496 nm, 565 nm / 578 nm
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS with 0.09% sodium azide and 0.5% BSA
Conditions de stockageStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment. 20ul contiennent 0,1% de BSA.

Informations générales

Asialoglycoprotein receptor (ASGPR), also known as the hepatic galactose/N-acetylglucosamine (GlcNAc) receptor or Ashwell receptor, is a C-type lectin expressed exclusively in hepatic parenchymal cells. ASGPR consists of two subunits, a major subunit (ASGR1, HL-1) and a minor subunit (ASGR2, HL-2), and specifically recognizes terminal β-linked galactose or GlcNAc on circulating glycoproteins or cells. This receptor plays a critical role in serum glycoprotein homeostasis by mediating the endocytosis and lysosomal degradation of glycoproteins that contain terminal galactose or GlcNAc residues. ASGPR may facilitate hepatic infection by multiple viruses including hepatitis B, and is also a target for liver-specific drug delivery.

Protocole

Product Specific Protocols
IF protocol for PE ASGR1 antibody PE-66692Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}